European Oncology & Haematology and Oncology & Hematology Review (US) are peer-reviewed, bi-annual journals specializing in the publication of balanced and comprehensive review articles written by leading authorities to address the most important and salient developments in the fields of oncology and hematology. The aim of these reviews is to break down the high science from 'data-rich' primary papers and provide practical advice and opinion on how this information can help physicians in the day to day clinical setting. Practice guidelines, symposium write-ups, case reports, and original research articles are also featured to promote discussion and learning amongst physicians, clinicians, researchers and related healthcare professionals.
The journal is of interest to physicians, health care professionals and researchers across Europe and the US, providing practical advice relevant to the clinical setting on the diagnosis and treatment of oncologic and hematologic conditions. European Oncology & Haematology and Oncology & Hematology Review (US) endeavour to support these professionals in continuously developing their knowledge, effectiveness and productivity.
Articles are independently commissioned by the journals Managing Editor following specialist advice from the Editorial Board, which features the most senior experts within Oncology &Hematology. Industry-sponsored articles that are balanced and pertinent are also welcomed. The Editor is always keen to hear from leading authorities wishing to discuss potential submissions. Please complete the form below and the Editor will be in touch regarding your proposal.
Touch Medical Media endeavours to publish unbiased, balanced reviews and studies and follow the publication guidelines as recommended by the ICMJE (www.icmje.org) and in the Good Publication Practice guidelines (www.ismpp.org/gpp2). All authors are asked to disclose personal, commercial, academic, and financial interests in the Disclosures section, along with any funding, financial support and medical writing assistance relating to the paper. All articles undergo a rigorous, double-blind peer review, conducted by at least two independent experts in the field to ensure articles are balanced, objective and relevant to the current clinical landscape. Please download our Instructions for Authors information for further details.
Aims & Scope and Instructions for Authors
ISSN NumbersEuropean Oncology & Haematology
Print ISSN: 2045-5275 Electronic ISSN: 2045-5283
Oncology & Hematology Review (US)
Print ISSN: 2052-3815 Electronic ISSN: 2052-3823